Tap Into UC Research and Development
With spending on industrial R&D decreasing as a percent overall budget, and universities finding increased focus on applied research and development, now is the time for your company to consider tapping into OCMI and UC research and development. Most commonly the interaction includes: (1) industrially sponsored research and development; (2) licensing and technology transfer. Industrially sponsored research and development occurs when industry has already has specific problem in mind, or increasingly when industry-OCMI partnerships are formed to explore new opportunities. The latter is the far more powerful approach and has led to the development of some of strongest OCMI programs. In addition, by working with OCMI your company is also able to tap into federal, state, and other funding to support R&D work at OCMI and your company.
Request Employer Training, Workshops, or Seminars
OCMI is able to go far beyond the traditional means of education, where your employee takes B.S. or graduate coursework. OCMI can offer customized seminars, training, workshops, or seminars for your employees.
Recruiting Full-time Engineers
UC’s Career Develop Center can work with you to post full-time positions and assist you recruiting candidates to meet your needs. Visit: http://www.uc.edu/career.html
UC’s world-renowned co-op program also provides the pathway to hire the best students to work within you organization: http://www.uc.edu/propractice/Employers.html
Industry Advisory Board
OCMI’s Industry advisory board is charged with networking of new opportunities for OCMI, guiding existing commercialization efforts, and providing leadership in the formation of a new industrial cluster in southwest Ohio based on microfluidic technologies. Applications currently include, medical devices, rapid and portable sensors, and consumer/household products.
The current board members are:
Aniruddha Puntambekar, PhD (Vice President, Strategic Planning and Operations), Siloam Biosciences (Cincinnati) - Dr. Puntambekar is proficient in the design and development of microfluidic systems for medical Point-Of-Care Testing systems. He has led the development of a paradigm shifting approach in developing the novel Optimiser™ microplate technology and extending its application beyond a lifescience consumable to a IVD/POCT system component. He is also closely involved with smart lab-on-a-chip based POCT system development project for over 10 years as a key researcher and a manager. Siloam Biosciences was founded in 2002 (in operation since 2004) with a vision of “Better Immunoassays and POCT through Innovative Microfluidics”. Siloam has its office and manufacturing facility of 8,000 square feet in the Forest Park suburb of Cincinnati, Ohio.
Sandra Degen, PhD. Professor, UC Department of Pediatrics, University of Cincinnati (Cincinnati) - Dr. Degen is currently Interim Chair, Dept of Molecular Genetics, Biochemistry & Microbiology and Associate Chair for Academic Affairs and Professor in the Department of Pediatrics, University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical Center. She was the Vice President for Research at the University of Cincinnati from 2004-2011,where she was responsible for all research compliance activities, the animal research program, sponsored research services, sponsored program accounting, entrepreneurial affairs, the intellectual property office, research educational programs and regional, state and federal advocacy with regard to research. Her research is interested in regulation of expression of proteins in blood coagulation and growth control: prothrombin; hepatocyte growth factor-like protein (HGFL) and its membrane tyrosine kinase receptor. Dr. Degen serves on the Board of Directors of Bio/Start and the Cincinnati Youth Collaborative. She was appointed by the Governor of Ohio to the Third Frontier Advisory Board from 2009 – 2011.
John Rudolph, President, Gamma Dynamics LLC (Cincinnati) – Mr. Rudolph’s experience includes VP of Business development for Corning Inc.’s subsidiary US Precision Lens, which grew its injection molding lens business from $38M to $250M in revenue over the years he ran business and product development. John has worked in materials and components for displays since 1981, including sitting on the board major U.S. firms involved in conventional microfabrication (Reflexite) and roll-to-roll microreplication (RPC Photonics). John’s current position, at Gamma Dynamics, involves leading the business development for a new class of reflective display devices based on microfluidic pixels.
John Nimmo, PhD, VP Colors Technology, Sun Chemical Company (Cincinnati) – John has thirty years experience in R&D in the inks and colorants industries. John has worked for Sun Chemical for 18 years, initially in Sun Chemical's Inks Division in Europe as R&D Manager, followed by a Business Improvement role in Europe and as a Program Director for a global ERP implementation. He is now VP of Colors Technology for Sun Chemical's Colors Group. He has thirty years experience in R&D in the inks and colorants industries. John holds a PhD from The University of Strathclyde in Glasgow, Scotland and has published and patented in the pigments and rheology fields. Role – OCMI partner in pigment dispersions for electrofluidic displays, and liquid dosing and sealing for other OCMI projects (lab-on-chip). In addition Sun Chemical is developing new materials and devices with application in medical point of care and energy efficient materials.
Dana Gruenbacher, Research Fellow, P&G (Cincinnati) for integration of microfluidic devices into household goods and sales/marketing to consumers. Dana has been with P&G since 1986 and holds a mechanical engineering degree from Kansas State and an MBA from Xavier University. He is a member of FEI (Front End Innovation) and has worked in a variety of products at P&G involving precision fluid handling.
Pat Longo, Director, Hamilton County Business Center (Cincinnati) Pat has been with the Hamilton County Business Center for 15 years now, currently serving as its director. Today, HCDC ranks 48th out of the approximately 300 Certified Development Companies (CDC) across the country, and is the only such entity which includes three distinct programs to promote economic development: a high loan volume SBA Certified Development Company, a large urban/county Economic Development Office and, an award-winning business incubation program. Pat previously worked as a Business Banking Officer at Bank One and a Business Banking Officer at Fifth Third Bank. He has a BSBA in Finance from John Carroll University.
Amal Assa'ad, MD, Professor and Director, Cincinnati Children’s Hospital, (Cincinnati) - Dr. Assa’ad is a Professor of the Department of Pediatrics at the University of Cincinnati, Associate Director of the Division of Allergy & Immunology Cincinnati Children's Hospital Medical Center, Director of the Fellowship Training Program, and Director of the Clinical Services. Her research and medical practice is interested in food allergy, asthma, vaccine allergy, and immune deficiencies.